Literature DB >> 22498247

The lessons of early-onset monogenic diabetes for the understanding of diabetes pathogenesis.

Martine Vaxillaire1, Amélie Bonnefond, Philippe Froguel.   

Abstract

Monogenic diabetes consists of different subtypes of single gene disorders comprising a large spectrum of phenotypes, namely neonatal diabetes mellitus or monogenic diabetes of infancy, dominantly inherited familial forms of early-onset diabetes (called Maturity-Onset Diabetes of the Young) and rarer diabetes-associated syndromic diseases. All these forms diagnosed at a very-young age are unrelated to auto-immunity. Their genetic dissection has revealed major genes in developmental and/or functional processes of the pancreatic β-cell physiology, and various molecular mechanisms underlying the primary pancreatic defects. Most of these discoveries have had remarkable consequences on the patients care and patient's long-term condition with outstanding examples of successful genomic medicine, which are highlighted in this chapter. Increasing evidence also shows that frequent polymorphisms in or near monogenic diabetes genes may contribute to adult polygenic type 2 diabetes. In this regard, unelucidated forms of monogenic diabetes represent invaluable models for identifying new targets of β-cell dysfunction.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22498247     DOI: 10.1016/j.beem.2011.12.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  22 in total

1.  Genetics of type 2 diabetes.

Authors:  Omar Ali
Journal:  World J Diabetes       Date:  2013-08-15

2.  Prevalence of monogenic diabetes in the population-based Norwegian Childhood Diabetes Registry.

Authors:  H U Irgens; J Molnes; B B Johansson; M Ringdal; T Skrivarhaug; D E Undlien; O Søvik; G Joner; A Molven; P R Njølstad
Journal:  Diabetologia       Date:  2013-04-27       Impact factor: 10.122

Review 3.  Recent advances in understanding the genetic architecture of type 2 diabetes.

Authors:  Karen L Mohlke; Michael Boehnke
Journal:  Hum Mol Genet       Date:  2015-07-09       Impact factor: 6.150

4.  Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry.

Authors:  Bente B Johansson; Henrik U Irgens; Janne Molnes; Paweł Sztromwasser; Ingvild Aukrust; Petur B Juliusson; Oddmund Søvik; Shawn Levy; Torild Skrivarhaug; Geir Joner; Anders Molven; Stefan Johansson; Pål R Njølstad
Journal:  Diabetologia       Date:  2016-12-02       Impact factor: 10.122

Review 5.  Epidemiology and Inherited Predisposition for Sporadic Pancreatic Adenocarcinoma.

Authors:  Rachael Z Stolzenberg-Solomon; Laufey T Amundadottir
Journal:  Hematol Oncol Clin North Am       Date:  2015-08       Impact factor: 3.722

6.  Etiologic distribution and clinical characteristics of pediatric diabetes in 276 children and adolescents with diabetes at a single academic center.

Authors:  Ja Hye Kim; Yena Lee; Yunha Choi; Gu-Hwan Kim; Han-Wook Yoo; Jin-Ho Choi
Journal:  BMC Pediatr       Date:  2021-03-04       Impact factor: 2.125

7.  Monogenic Diabetes and Integrated Stress Response Genes Display Altered Gene Expression in Type 1 Diabetes.

Authors:  Helmut Hiller; Dawn E Beachy; Joseph J Lebowitz; Stefanie Engler; Justin R Mason; Douglas R Miller; Irina Kusmarteva; Laura M Jacobsen; Amanda L Posgai; Habibeh Khoshbouei; Richard A Oram; Desmond A Schatz; Andrew T Hattersley; Bernd Bodenmiller; Mark A Atkinson; Harry S Nick; Clive H Wasserfall
Journal:  Diabetes       Date:  2021-05-25       Impact factor: 9.337

8.  Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes.

Authors:  Serena Pezzilli; Tommaso Mazza; Maria Giovanna Scarale; Yaling Tang; Francesco Andreozzi; Marco Giorgio Baroni; Raffaella Buzzetti; Maria Gisella Cavallo; Efisio Cossu; Paola D'Angelo; Salvatore De Cosmo; Olga Lamacchia; Frida Leonetti; Susanna Morano; Lelio Morviducci; Giuseppe Penno; Paolo Pozzilli; Giuseppe Pugliese; Giorgio Sesti; Alessandro Doria; Vincenzo Trischitta; Sabrina Prudente
Journal:  Acta Diabetol       Date:  2022-02-03       Impact factor: 4.087

9.  Reassessment of the putative role of BLK-p.A71T loss-of-function mutation in MODY and type 2 diabetes.

Authors:  A Bonnefond; L Yengo; J Philippe; A Dechaume; I Ezzidi; E Vaillant; A P Gjesing; E A Andersson; S Czernichow; S Hercberg; S Hadjadj; G Charpentier; O Lantieri; B Balkau; M Marre; O Pedersen; T Hansen; P Froguel; M Vaxillaire
Journal:  Diabetologia       Date:  2012-12-06       Impact factor: 10.122

Review 10.  Genome Editing Human Pluripotent Stem Cells to Model β-Cell Disease and Unmask Novel Genetic Modifiers.

Authors:  Matthew N George; Karla F Leavens; Paul Gadue
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-02       Impact factor: 6.055

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.